The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Lantern Pharma Inc(NASDAQ:LTRN) 
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on the development of precision oncology therapies using artificial intelligence, genomics, and machine learning. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant...
Website: http://www.lanternpharma.com
Founded: 2013
Full Time Employees: 4
CEO: Panna L. Sharma
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Lantern Pharma Days Payable Outstanding ttm (DPO)
Lantern Pharma Op Cashflow Per Share ttm
Lantern Pharma Free Cashflow Per Share ttm
Lantern Pharma Cash Per Share ttm
Lantern Pharma (GAAP) P/E ratio ttm
Lantern Pharma P/B ratio ttm
No extra charts and metrics for this ticker.